Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/15/2022 | 53.61% | Jefferies | → $10 | Initiates Coverage On | → Buy |
The Oncology Institute Questions & Answers
The latest price target for The Oncology Institute (NASDAQ: TOI) was reported by Jefferies on August 15, 2022. The analyst firm set a price target for $10.00 expecting TOI to rise to within 12 months (a possible 53.61% upside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for The Oncology Institute (NASDAQ: TOI) was provided by Jefferies, and The Oncology Institute initiated their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of The Oncology Institute, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for The Oncology Institute was filed on August 15, 2022 so you should expect the next rating to be made available sometime around August 15, 2023.
While ratings are subjective and will change, the latest The Oncology Institute (TOI) rating was a initiated with a price target of $0.00 to $10.00. The current price The Oncology Institute (TOI) is trading at is $6.51, which is within the analyst's predicted range.